Cart
sales@molnova.com
Home - Products - Cell Cycle/DNA Damage - ATM/ATR - Lartesertib

Lartesertib

Lartesertib

Catalog No. M35661

Lartesertib (ATM Inhibitor-5) is an inhibitor of serine/threonine protein kinase ATM with potential anticancer activity for the study of lung cancer.

Size Price / USD Stock Quantity
2MG 201 Get Quote
5MG 312 Get Quote
10MG 534 Get Quote
25MG 1003 Get Quote
50MG 1674 Get Quote
100MG 2538 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Lartesertib
  • Brief Description
  • Description
  • Storage
  • Note
    Research use only, not for human use.
  • Reference
    1. Alessandra AMBRUOSI, et al. Pharmaceutical preparation. WO2022058351A1.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • CP-466722

    A poten and selective ATM inhibitor without effect on ATR kinase; does not inhibit PI3K, PI3K-like protein kinases or Abl kinase and disrupts ATM-dependent cell cycle checkpoints in cells.

  • Arg-Gly-Asp TFA

    RGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; binds to?integrins.

  • Camonsertib

    Camonsertib (RP-3500) is a novel, potent and selective ATR kinase inhibitor (ATRi) that exhibits potent antitumor effects with an IC50: 1.00 nM in biochemical assays.

Sign In Join Free